← Back to patent-cliff list
CAS 1032350-03-0
tert-butyl (1-(4-(3-hydroxy-9-phenyl-[1,2,4]triazolo[3,4-f][1,6]naphthyridin-8-yl)phenyl)cyclobutyl)carbamate
Codes: MK-2206-008
Application context (from source-drug indications)
Peritoneal cancerMK-2206Prostate cancerMK-2206Small cell lung cancerMK-2206胸腺瘤MK-2206Non-small cell lung cancerMK-2206皮肤黑色素瘤MK-2206
Source drugs (routes using this intermediate)
| Drug | Tier | Expiry |
|---|---|---|
| MK-2206 | Tier C — Watch / trade | - |
Position in synthesis routes (up/downstream chain)
Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.
1-(4-chlorophenyl)cyclobutane-1-carboxylic acid→tert-butyl (1-(4-chlorophenyl)cyclobutyl)carbamate→tert-butyl (1-(4-cyanophenyl)cyclobutyl)carbamate→tert-butyl (1-(4-(2-phenylacetyl)phenyl)cyclobutyl)carbamate→tert-butyl (2-chloro-3-formylpyridin-4-yl)carbamate→tert-butyl (1-(4-(5-chloro-3-phenyl-1,6-naphthyridin-2-yl)phenyl)cyclobutyl)carbamate→tert-butyl (1-(4-(5-hydrazineyl-3-phenyl-1,6-naphthyridin-2-yl)phenyl)cyclobutyl)carbamate→tert-butyl (1-(4-(3-hydroxy-9-phenyl-[1,2,4]triazolo[3,4-f][1,6]naphthyridin-8-yl)phenyl)cyclobutyl)carbamate
Intermediates available on this site
No listed intermediates for this target yet — send an RFQ directly and it will enter our matching pool.
This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.